» Articles » PMID: 34922430

Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment

Abstract

The Korean Society of Nephrology (KSN) has published a clinical practice guideline (CPG) document for maintenance hemodialysis (HD). The document, 2021 Clinical Practice Guideline on Optimal HD Treatment, is based on an extensive evidence-oriented review of the benefits of preparation, initiation, and maintenance therapy for HD, with the participation of representative experts from the KSN under the methodologists' support for guideline development. It was intended to help clinicians participating in HD treatment make safer and more effective clinical decisions by providing user-friendly guidelines. We hope that this CPG will be meaningful as a recommendation in practice, but not on a regulatory rule basis, as different approaches and treatments may be used by health care providers depending on the individual patient's condition. This CPG consists of eight sections and 15 key questions. Each begins with statements that are graded by the strength of recommendations and quality of the evidence. Each statement is followed by a summary of the evidence supporting the recommendations. There is also a link to full-text documents and lists of the most important reports so that the readers can read further (most of this is available online).

Citing Articles

Management of high-flow arteriovenous access.

Park H, Shin S Kidney Res Clin Pract. 2025; 44(1):58-68.

PMID: 39923807 PMC: 11838845. DOI: 10.23876/j.krcp.23.196.


Predicting early mortality in hemodialysis patients: a deep learning approach using a nationwide prospective cohort in South Korea.

Noh J, Park S, Bae W, Kim K, Cho J, Lee J Sci Rep. 2024; 14(1):29658.

PMID: 39609495 PMC: 11604665. DOI: 10.1038/s41598-024-80900-6.


Monitoring and maintaining quality in the paediatric haemodialysis unit.

Uthup S, Balan S, Lobo V Pediatr Nephrol. 2024; 40(4):909-921.

PMID: 39466389 DOI: 10.1007/s00467-024-06559-3.


Which blood pressure metrics should be used in patients on dialysis?.

Jung J Kidney Res Clin Pract. 2023; 43(2):133-142.

PMID: 38062622 PMC: 11016667. DOI: 10.23876/j.krcp.23.126.


Optimal hemodialysis treatment for pediatric kidney failure patients.

Ahn Y Clin Exp Pediatr. 2023; 66(3):125-126.

PMID: 36789490 PMC: 9989721. DOI: 10.3345/cep.2022.01431.

References
1.
Chesterton L, Selby N, Burton J, McIntyre C . Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability. Hemodial Int. 2009; 13(2):189-96. DOI: 10.1111/j.1542-4758.2009.00355.x. View

2.
Zhang Y, Hu C, Bian Z, Chen P . Impact of timing of initiation of dialysis on long-term prognosis of patients undergoing hemodialysis. Exp Ther Med. 2018; 16(2):1209-1215. PMC: 6090211. DOI: 10.3892/etm.2018.6281. View

3.
Locatelli F, Andrulli S, Pecchini F, Pedrini L, Agliata S, Lucchi L . Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol Dial Transplant. 2000; 15(9):1399-409. DOI: 10.1093/ndt/15.9.1399. View

4.
Tsujimoto Y, Tsujimoto H, Nakata Y, Kataoka Y, Kimachi M, Shimizu S . Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis. Cochrane Database Syst Rev. 2019; 7:CD012598. PMC: 6609546. DOI: 10.1002/14651858.CD012598.pub2. View

5.
Eknoyan G, Beck G, Cheung A, Daugirdas J, Greene T, Kusek J . Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002; 347(25):2010-9. DOI: 10.1056/NEJMoa021583. View